Corticosteroid-Associated Adverse Events in Chronic Spontaneous Urticaria: A US Claims Data Study - Summary - MDSpire

Corticosteroid-Associated Adverse Events in Chronic Spontaneous Urticaria: A US Claims Data Study

  • By

  • Gil Yosipovitch

  • Dhaval Patil

  • Jonathan Rodrigues

  • Merin Kuruvilla

  • Tara Raftery

  • Irina Pivneva

  • Jason Doran

  • Arthur Voegel

  • James Signorovitch

  • Marc A. Riedl

  • May 5, 2026

  • 0 min

Share

Objective:

To explore adverse events (AEs) and health care resource utilization (HCRU) associated with corticosteroid use in a large US patient cohort with chronic spontaneous urticaria (CSU), highlighting the significance of real-world data in understanding treatment risks.

Key Findings:
  • Common AEs after corticosteroid initiation included hypertension, lipid disorders, and anxiety, underscoring the need for careful monitoring.
  • Longer corticosteroid use correlated with higher rates of acute and chronic AEs and increased AE-related HCRU, indicating a need for more effective management strategies.
  • Corticosteroid-sparing measures are necessary to reduce patient risk and healthcare burden, emphasizing the importance of alternative treatments.
Interpretation:

The study highlights significant risks associated with prolonged corticosteroid use in CSU patients, emphasizing the need for alternative management strategies to mitigate these risks.

Limitations:
  • The study relied on claims data, which may not capture all relevant clinical information, potentially affecting the comprehensiveness of the findings.
  • Potential biases in patient selection and reporting of AEs may exist, which could influence the study's conclusions.
Conclusion:

Optimizing corticosteroid-sparing strategies is crucial in managing CSU to minimize adverse events and healthcare resource utilization, reinforcing the need for ongoing research in this area.

Original Source(s)

Related Content